|
2003
OMIG, Abstract 9
OMIG
Main Page | 2003
Abstracts | <
Previous | Next>
The
Effect of Cataract Surgery on Ocular Levels of Topical Moxifloxacin
Rookaya Mather1,2, Jay Stewart2, Tisha Prabriputaloong1,2,
Stephen D. McCleod1,2. 1Francis I. Proctor
Foundation, San Francisco, 2Cornea Service, Department
of Ophthalmology, University of California, San Francisco
Purpose:
To investigate the effect of cataract surgery on the concentration
of moxifloxacin in the aqueous and vitreous after topical application
in a rabbit model.
Design: A prospective laboratory intervention design
using a rabbit model to study the effect of cataract surgery on
the ocular concentrations of topically-administered moxifloxacin
in operated eyes vs. non-operated eyes.
Methods: Following the administration of topical
0.5% moxifloxacin, 60 minutes before surgery and immediately post-cataract
surgery, aqueous and vitreous humors were sampled at 30, 60 and
120 minutes post-surgery. Moxifloxacin concentrations were determined
by High Pressure Liquid Chromatography and mean tissue concentrations
obtained in surgical eyes were compared to the concentrations obtained
in non-surgical control eyes. The potential effectiveness of moxifloxacin
in providing prophylaxis against intracameral bacterial inoculation
was investigated by comparing antibiotic concentrations measured
over the first two hours after surgery to Minimum Inhibitory Concentration
values for S. aureus and S. epidermidis.
Results: In surgical eyes moxifloxacin concentrations
in aqueous, were 13.88, 16.18 and 12.18µg/ml vs. 25.32, 32.64
and 15.69µg/ml in non-operated eyes at 30, 60 and 120 minutes,
respectively. No statistically significant differences were found
when surgical and non-surgical eyes were compared. In surgical eyes
moxifloxacin concentrations in vitreous, were 66.84, 66.62 and 400.23ng/ml
vs. 43.09, 199.80 and 54.44ng/ml in non-operated eyes at 30, 60
and 120 minutes, respectively. No statistically significant differences
were found when surgical and non-surgical eyes were compared.
Conclusions: Cataract surgery does not substantially
alter the penetration of topical antibiotics compared to the un-operated
eye. In the case of moxifloxacin, as indicated by this model, a
multiple drop dosing schedule produced aqueous concentrations that
were well above the Minimum Inhibitory Concentrations of even resistant
strains of the most common organisms implicated in post-cataract
endophthalmitis.
Financial Support:
Unrestricted research grant from Alcon Pharmaceutical, Fort Worth
Texas. The authors have no proprietary interest in any of the products
presented in this study.
OMIG
Main Page | 2003
Abstracts | <
Previous | Next>
|
|
|